MIAMI, April 30, 2009 (GLOBE NEWSWIRE) -- Noven Pharmaceuticals, Inc. (Nasdaq:NOVN) today announced its 2009 first quarter earnings release date.
On May 7, before the U.S. market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter ended March 31, 2009. At 11:00 a.m. ET the same day, a conference call with management is scheduled to be webcast live at www.noven.com, and thereafter a rebroadcast will be available at the same site for at least two weeks. A taped replay of the call will be available beginning May 7 through May 11 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering the access code 286 and conference ID number 320515.
About Noven
Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven's business and operations are focused in three principal areas -- transdermal drug delivery, the Novogyne Pharmaceuticals joint venture, and Noven Therapeutics, Noven's specialty pharmaceuticals unit. Noven is committed to developing and offering products and technologies that meaningfully benefit patients, its customers and its industry partners. For more information, visit www.noven.com.
The Noven Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5938